Polivy 30mg (Polatuzumab Vedotin Vials) 30mg

Polivy 30mg is a prescription medication used in cancer treatment. It contains polatuzumab vedotin, designed for intravenous infusion. Store between 2-8°C to maintain potency. Always consult a healthcare provider before use.

Strength

30mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Polivy 30mg is used to treat certain types of cancer, including diffuse large B-cell lymphoma. It works by targeting cancer cells to slow their growth. This medication is often combined with other cancer therapies for enhanced effectiveness. Patients may wonder, 'what is Polivy 30mg used for?' as part of their treatment discussions.

Side Effects

Polivy 30mg may cause side effects such as fatigue, nausea, or low blood cell counts. Some patients experience hair loss or digestive discomfort. These effects vary by individual and should be monitored by a healthcare professional. Regular check-ups help track progress and manage any concerns.

Precautions & Warnings

Polivy 30mg requires careful handling and storage at 2-8°C. Avoid freezing or exposing to high temperatures. Patients should inform their doctor about all medications and health conditions before starting treatment. Pregnant or breastfeeding individuals should discuss risks with their healthcare provider.

Avoid Interactions

Polivy 30mg may interact with other medications, including CYP3A inhibitors or inducers. Alcohol and certain supplements could affect its efficacy or increase side effects. Always disclose all current medications to your doctor to prevent potential interactions. Monitoring is recommended during combined therapies.

Frequently Asked Questions

Polivy 30mg is used to treat certain cancers, such as diffuse large B-cell lymphoma, often in combination with other therapies.

Polivy 30mg is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects include fatigue, nausea, and low blood cell counts. Discuss any concerns with your doctor.

No, Polivy 30mg must be stored between 2-8°C to maintain its effectiveness.

Pregnant or breastfeeding individuals should consult their doctor before using Polivy 30mg due to potential risks.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.